ペプチドリームの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2023/04/18 | 1,930 | 1,964 | 1,923 | 1,929 | +14 | +0.7% | 444,300 |
2023/04/17 | 1,937 | 1,937 | 1,902 | 1,915 | -21 | -1.1% | 389,300 |
2023/04/14 | 1,953 | 1,960 | 1,928 | 1,936 | +13 | +0.7% | 386,600 |
2023/04/13 | 1,882 | 1,923 | 1,876 | 1,923 | +19 | +1% | 421,800 |
2023/04/12 | 1,920 | 1,935 | 1,895 | 1,904 | +4 | +0.2% | 441,100 |
2023/04/11 | 1,952 | 1,960 | 1,900 | 1,900 | -43 | -2.2% | 453,900 |
2023/04/10 | 1,922 | 1,956 | 1,910 | 1,943 | +21 | +1.1% | 483,900 |
2023/04/07 | 1,903 | 1,928 | 1,890 | 1,922 | +28 | +1.5% | 609,800 |
2023/04/06 | 1,823 | 1,899 | 1,816 | 1,894 | +48 | +2.6% | 595,200 |
2023/04/05 | 1,876 | 1,891 | 1,844 | 1,846 | -51 | -2.7% | 351,200 |
2023/04/04 | 1,919 | 1,927 | 1,872 | 1,897 | -14 | -0.7% | 563,800 |
2023/04/03 | 1,916 | 1,953 | 1,899 | 1,911 | +32 | +1.7% | 810,500 |
2023/03/31 | 1,891 | 1,910 | 1,862 | 1,879 | +15 | +0.8% | 454,400 |
2023/03/30 | 1,851 | 1,893 | 1,841 | 1,864 | +32 | +1.7% | 602,400 |
2023/03/29 | 1,762 | 1,832 | 1,747 | 1,832 | +53 | +3% | 742,300 |
2023/03/28 | 1,783 | 1,791 | 1,760 | 1,779 | -10 | -0.6% | 793,000 |
2023/03/27 | 1,795 | 1,807 | 1,761 | 1,789 | -3 | -0.2% | 584,900 |
2023/03/24 | 1,830 | 1,832 | 1,780 | 1,792 | -23 | -1.3% | 509,700 |
2023/03/23 | 1,788 | 1,823 | 1,780 | 1,815 | -8 | -0.4% | 616,900 |
2023/03/22 | 1,798 | 1,839 | 1,795 | 1,823 | +35 | +2% | 599,100 |
2023/03/20 | 1,826 | 1,835 | 1,771 | 1,788 | -36 | -2% | 633,400 |
2023/03/17 | 1,787 | 1,824 | 1,781 | 1,824 | +35 | +2% | 486,300 |
2023/03/16 | 1,755 | 1,800 | 1,755 | 1,789 | +4 | +0.2% | 522,500 |
2023/03/15 | 1,792 | 1,802 | 1,768 | 1,785 | +9 | +0.5% | 612,600 |
2023/03/14 | 1,779 | 1,805 | 1,760 | 1,776 | -16 | -0.9% | 660,200 |
2023/03/13 | 1,800 | 1,809 | 1,776 | 1,792 | -48 | -2.6% | 730,800 |
2023/03/10 | 1,852 | 1,872 | 1,831 | 1,840 | -33 | -1.8% | 805,800 |
2023/03/09 | 1,836 | 1,883 | 1,835 | 1,873 | +54 | +3% | 931,300 |
2023/03/08 | 1,818 | 1,838 | 1,809 | 1,819 | +5 | +0.3% | 680,200 |
2023/03/07 | 1,788 | 1,818 | 1,782 | 1,814 | +9 | +0.5% | 747,300 |
2023/03/06 | 1,822 | 1,833 | 1,798 | 1,805 | +8 | +0.4% | 512,900 |
2023/03/03 | 1,775 | 1,806 | 1,771 | 1,797 | +37 | +2.1% | 599,800 |
2023/03/02 | 1,750 | 1,770 | 1,737 | 1,760 | -24 | -1.3% | 756,900 |
2023/03/01 | 1,849 | 1,854 | 1,766 | 1,784 | -65 | -3.5% | 1,141,400 |
2023/02/28 | 1,848 | 1,871 | 1,821 | 1,849 | +61 | +3.4% | 927,100 |
2023/02/27 | 1,786 | 1,808 | 1,771 | 1,788 | -49 | -2.7% | 752,500 |
2023/02/24 | 1,810 | 1,857 | 1,760 | 1,837 | +12 | +0.7% | 1,110,000 |
2023/02/22 | 1,810 | 1,835 | 1,794 | 1,825 | -20 | -1.1% | 750,800 |
2023/02/21 | 1,891 | 1,910 | 1,837 | 1,845 | -30 | -1.6% | 889,500 |
2023/02/20 | 1,851 | 1,891 | 1,837 | 1,875 | -12 | -0.6% | 660,900 |
2023/02/17 | 1,898 | 1,911 | 1,837 | 1,887 | -47 | -2.4% | 1,667,900 |
2023/02/16 | 1,894 | 1,966 | 1,894 | 1,934 | +54 | +2.9% | 1,263,000 |
2023/02/15 | 1,960 | 1,992 | 1,875 | 1,880 | -206 | -9.9% | 2,698,200 |
2023/02/14 | 2,071 | 2,098 | 2,063 | 2,086 | +9 | +0.4% | 672,900 |
2023/02/13 | 2,045 | 2,091 | 2,041 | 2,077 | +14 | +0.7% | 467,200 |
2023/02/10 | 2,106 | 2,106 | 2,041 | 2,063 | -44 | -2.1% | 889,800 |
2023/02/09 | 2,040 | 2,117 | 2,037 | 2,107 | +42 | +2% | 913,800 |
2023/02/08 | 2,035 | 2,069 | 2,000 | 2,065 | +38 | +1.9% | 910,400 |
2023/02/07 | 2,011 | 2,058 | 2,007 | 2,027 | +27 | +1.4% | 991,700 |
2023/02/06 | 2,020 | 2,041 | 1,993 | 2,000 | +2 | +0.1% | 588,300 |
501~
550
件表示中 / 2908件
類似銘柄と比較する
現在ご覧いただいている「ペプチド」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ペプチド | 190,600円 | +5.0% | +1.5% | 0.00% | 16.36倍 | 4.35倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
住友ファーマ | 89,900円 | +26.8% | - | 0.00% | 15.13倍 | 3.13倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
ツムラ | 432,700円 | +20.9% | +87.3% | 3.14% | 9.66倍 | 1.11倍 |
|
医療用漢方薬で国内シェア8割超。高齢者、がん支持療法、女性関連の3領域を重点に市場深耕 |
日本新薬 | 348,400円 | +7.9% | +8.9% | 3.56% | 7.45倍 | 1.00倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
サワイGHD | 201,600円 | +4.0% | +25.4% | 2.63% | 8.82倍 | 1.16倍 |
|
ジェネリック(後発)薬大手メーカー。21年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
市場注目の銘柄
チャート関連のコラム